Use of multiple sclerosis disease-modifying therapies during pregnancy in France from 2010 to 2021

被引：0
|
作者：
Swital, Morgane [1 ]
Drouin, Jerome [2 ]
Miranda, Sara [2 ]
Botton, Jeremie [1 ]
Dray-Spira, Rosemary [1 ]
机构：
[1] EPI PHARE, St Denis, France
[2] EPI PHARE, ANSM, CNAM, St Denis, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1119
引用
收藏
页码：526 / 527
页数：2
相关论文
共 50 条
  • [1] Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021
    Swital, Morgane
    Drouin, Jerome
    Miranda, Sara
    Bakchine, Serge
    Botton, Jeremie
    Dray-Spira, Rosemary
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 227 - 237
  • [2] Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies
    Tillaut, Helene
    Degremont, Adeline
    Kerbrat, Sandrine
    Roux, Jonathan
    Le Page, Emmanuelle
    Mainguy, Christelle
    Duros, Solene
    Polard, Elisabeth
    Leray, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 778 - 789
  • [3] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
  • [4] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
  • [5] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [6] Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
    Simone, Isabella Laura
    Tortorella, Carla
    Ghirelli, Alma
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [7] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [8] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [9] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
  • [10] Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
    Alroughani, Raed
    Altintas, Ayse
    Al Jumah, Mohammed
    Sahraian, Mohammadali
    Alsharoqi, Issa
    AlTahan, Abdurahman
    Daif, Abdulkader
    Dahdaleh, Maurice
    Deleu, Dirk
    Fernandez, Oscar
    Grigoriadis, Nikolaos
    Inshasi, Jihad
    Karabudak, Rana
    Taha, Karim
    Totolyan, Natalia
    Yamout, Bassem I.
    Zakaria, Magd
    Bohlega, Saeed
    MULTIPLE SCLEROSIS INTERNATIONAL, 2016, 2016
12345